187 related articles for article (PubMed ID: 30199470)
1. Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.
Gilligan AM; Foster SA; Sainski-Nguyen A; Sedgley R; Smith D; Morrow P
J Occup Environ Med; 2018 Dec; 60(12):1120-1127. PubMed ID: 30199470
[TBL] [Abstract][Full Text] [Related]
2. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
3. The direct and indirect costs among U.S. privately insured employees with hypogonadism.
Kaltenboeck A; Foster S; Ivanova J; Diener M; Bergman R; Birnbaum H; Kinchen K; Swindle R
J Sex Med; 2012 Sep; 9(9):2438-47. PubMed ID: 22738380
[TBL] [Abstract][Full Text] [Related]
4. The Direct and Indirect Costs Associated With Overactive Bladder Within a Commercially-Insured Population in the United States.
Durden E; Walker D; Gray S; Fowler R; Juneau P; Gooch K
J Occup Environ Med; 2018 Sep; 60(9):847-852. PubMed ID: 29851742
[TBL] [Abstract][Full Text] [Related]
5. Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
Parasuraman S; Thiel E; Park J; Teschemaker A
J Med Econ; 2023; 26(1):454-462. PubMed ID: 36883994
[TBL] [Abstract][Full Text] [Related]
6. Indirect costs associated with metastatic breast cancer.
Wan Y; Gao X; Mehta S; Wang Z; Faria C; Schwartzberg L
J Med Econ; 2013 Oct; 16(10):1169-78. PubMed ID: 23866016
[TBL] [Abstract][Full Text] [Related]
7. Societal burden of cluster headache in the United States: a descriptive economic analysis.
Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
[TBL] [Abstract][Full Text] [Related]
8. Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine.
Buse DC; Yugrakh MS; Lee LK; Bell J; Cohen JM; Lipton RB
J Manag Care Spec Pharm; 2020 Oct; 26(10):1334-1343. PubMed ID: 32678721
[TBL] [Abstract][Full Text] [Related]
9. Migraine burden and costs in France: a nationwide claims database analysis of triptan users.
Donnet A; Emery C; Aly S; Allaf B; Cayre F; Mahieu N; Gourmelen J; Levy P; Fagnani F
J Med Econ; 2019 Jul; 22(7):616-624. PubMed ID: 30836035
[No Abstract] [Full Text] [Related]
10. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET
Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.
Lublóy Á
BMC Public Health; 2019 Sep; 19(1):1242. PubMed ID: 31500616
[TBL] [Abstract][Full Text] [Related]
13. The direct and indirect cost burden of Crohn's disease and ulcerative colitis.
Gibson TB; Ng E; Ozminkowski RJ; Wang S; Burton WN; Goetzel RZ; Maclean R
J Occup Environ Med; 2008 Nov; 50(11):1261-72. PubMed ID: 19001952
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of sarcoidosis in a commercially-insured population in the United States.
Rice JB; White A; Lopez A; Conway A; Wagh A; Nelson WW; Philbin M; Wan GJ
J Med Econ; 2017 Oct; 20(10):1048-1055. PubMed ID: 28678623
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
[TBL] [Abstract][Full Text] [Related]
16. The direct and indirect costs of untreated insomnia in adults in the United States.
Ozminkowski RJ; Wang S; Walsh JK
Sleep; 2007 Mar; 30(3):263-73. PubMed ID: 17425222
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of epilepsy among the privately insured in the US.
Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S
Pharmacoeconomics; 2010; 28(8):675-85. PubMed ID: 20623993
[TBL] [Abstract][Full Text] [Related]
18. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
[TBL] [Abstract][Full Text] [Related]
19. Burden of migraine in the United States: disability and economic costs.
Hu XH; Markson LE; Lipton RB; Stewart WF; Berger ML
Arch Intern Med; 1999 Apr; 159(8):813-8. PubMed ID: 10219926
[TBL] [Abstract][Full Text] [Related]
20. United States comparative costs and absenteeism of diabetic ophthalmic conditions.
Brook RA; Kleinman NL; Patel S; Smeeding JE; Beren IA; Turpcu A
Postgrad Med; 2015 Jun; 127(5):455-62. PubMed ID: 25549691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
